168 related articles for article (PubMed ID: 36367014)
1. Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney disease.
Nakano Y; Murakami M; Hara K; Fukuda T; Horino M; Takeuchi A; Niitsu Y; Shiba K; Tsujimoto K; Komiya C; Yokoyama M; Ikeda K; Yoshimoto T; Fujii Y; Yamada T
Clin Endocrinol (Oxf); 2023 Mar; 98(3):323-331. PubMed ID: 36367014
[TBL] [Abstract][Full Text] [Related]
2. Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.
Kobayashi H; Abe M; Nakamura Y; Takahashi K; Fujita M; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Wada N; Ichijo T; Katabami T; Ogawa Y; Kawashima J; Yoshimoto T; Sone M; Inagaki N; Watanabe M; Kamemura K; Matsuda Y; Izawa S; Tanabe M; Tanabe A; Suzuki T; Naruse M;
Hypertension; 2019 Sep; 74(3):630-638. PubMed ID: 31327258
[TBL] [Abstract][Full Text] [Related]
3. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.
Iwakura Y; Morimoto R; Kudo M; Ono Y; Takase K; Seiji K; Arai Y; Nakamura Y; Sasano H; Ito S; Satoh F
J Clin Endocrinol Metab; 2014 May; 99(5):1593-8. PubMed ID: 24285678
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism.
Watanabe D; Morimoto S; Morishima N; Ichihara A
Endocrine; 2024 Apr; 84(1):245-252. PubMed ID: 38087188
[TBL] [Abstract][Full Text] [Related]
5. Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy.
Nakano Y; Yoshimoto T; Fukuda T; Murakami M; Bouchi R; Minami I; Hashimoto K; Fujii Y; Kihara K; Ogawa Y
Intern Med; 2018 Sep; 57(17):2459-2466. PubMed ID: 29709927
[TBL] [Abstract][Full Text] [Related]
6. Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function.
Kim IY; Park IS; Kim MJ; Han M; Rhee H; Seong EY; Lee DW; Lee SB; Kwak IS; Song SH; Chung HC
Int Urol Nephrol; 2018 Oct; 50(10):1887-1895. PubMed ID: 29779118
[TBL] [Abstract][Full Text] [Related]
7. Worsening of lipid metabolism after successful treatment of primary aldosteronism.
Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M
Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655
[TBL] [Abstract][Full Text] [Related]
8. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
Hypertension; 2018 Sep; 72(3):658-666. PubMed ID: 29987110
[TBL] [Abstract][Full Text] [Related]
9. [Chronic kidney disease after adrenalectomy in a patient with primary aldosteronism].
An WC; Yan HX; Deng ZZ; Chen F; Ou XH; Jin HX; Huang W
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1201-1204. PubMed ID: 34916706
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism.
Kim DH; Kwon HJ; Ji SA; Jang HR; Jung SH; Kim JH; Kim JH; Lee JE; Huh W; Kim YG; Kim DJ; Oh HY
Medicine (Baltimore); 2016 Jul; 95(27):e3930. PubMed ID: 27399066
[TBL] [Abstract][Full Text] [Related]
11. Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism.
Nakamaru R; Yamamoto K; Akasaka H; Rakugi H; Kurihara I; Yoneda T; Ichijo T; Katabami T; Tsuiki M; Wada N; Yamada T; Kobayashi H; Tamura K; Ogawa Y; Kawashima J; Inagaki N; Fujita M; Watanabe M; Kamemura K; Okamura S; Tanabe A; Naruse M;
Sci Rep; 2021 Mar; 11(1):6925. PubMed ID: 33767283
[TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease score for predicting postoperative masked renal insufficiency in patients with primary aldosteronism.
Tanase-Nakao K; Naruse M; Nanba K; Tsuiki M; Tagami T; Usui T; Okuno H; Shimatsu A; Hashimoto S; Katabami T; Ogo A; Okumura A; Umakoshi H; Suzuki T
Clin Endocrinol (Oxf); 2014 Nov; 81(5):665-70. PubMed ID: 24821606
[TBL] [Abstract][Full Text] [Related]
13. Effects of Treating Primary Aldosteronism on Renal Function.
Kramers BJ; Kramers C; Lenders JW; Deinum J
J Clin Hypertens (Greenwich); 2017 Mar; 19(3):290-295. PubMed ID: 27659389
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.
Katabami T; Fukuda H; Tsukiyama H; Tanaka Y; Takeda Y; Kurihara I; Ito H; Tsuiki M; Ichijo T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Yanase T; Suzuki T; Naruse M;
J Hypertens; 2019 Jul; 37(7):1513-1520. PubMed ID: 31145370
[TBL] [Abstract][Full Text] [Related]
15. Does the temporary decrease in the estimated glomerular filtration rate (eGFR) after initiation of mineralocorticoid receptor (MR) antagonist treatment lead to a long-term renal protective effect?
Sato A
Hypertens Res; 2019 Dec; 42(12):1841-1847. PubMed ID: 31492909
[TBL] [Abstract][Full Text] [Related]
16. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
[TBL] [Abstract][Full Text] [Related]
17. Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function.
Haze T; Yano Y; Hatano Y; Tamura K; Kurihara I; Kobayashi H; Tsuiki M; Ichijo T; Wada N; Katabami T; Yamamoto K; Okamura S; Kai T; Izawa S; Yoshikawa Y; Yamada M; Chiba Y; Tanabe A; Naruse M;
J Hum Hypertens; 2022 Oct; 36(10):904-910. PubMed ID: 34462544
[TBL] [Abstract][Full Text] [Related]
18. Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism.
Utsumi T; Kamiya N; Kaga M; Endo T; Yano M; Kamijima S; Kawamura K; Imamoto T; Ichikawa T; Suzuki H
World J Urol; 2017 Oct; 35(10):1577-1583. PubMed ID: 28401356
[TBL] [Abstract][Full Text] [Related]
19. Is acute kidney injury after laparoscopic adrenalectomy related to the progression of chronic kidney disease in patients with primary aldosteronism?
Yoon JH; Chung HS; Hong AR; Kim HK; Kang HC; Kim MS; Hwang EC; Jung SI; Park K; Kwon D
Investig Clin Urol; 2021 Sep; 62(5):560-568. PubMed ID: 34387032
[TBL] [Abstract][Full Text] [Related]
20. Association of Reversal of Renin Suppression With Long-Term Renal Outcome in Medically Treated Primary Aldosteronism.
Katsuragawa S; Goto A; Shinoda S; Inoue K; Nakai K; Saito J; Nishikawa T; Tsurutani Y
Hypertension; 2023 Sep; 80(9):1909-1920. PubMed ID: 37449450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
